Seidman A - Search Results

1

Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: feasibility and efficacy.

Hudis C, Seidman A, Baselga J, Raptis G, Lebwohl D, Gilewski T, Moynahan M, Sklarin N, Fennelly D, Crown JP, Surbone A, Uhlenhopp M, Riedel E, Yao TJ, Norton L. Hudis C, et al. Among authors: seidman a. J Clin Oncol. 1999 Jan;17(1):93-100. doi: 10.1200/JCO.1999.17.1.93. J Clin Oncol. 1999. PMID: 10458222 Clinical Trial.

2

The evolving role of chemotherapy for muscle infiltrating bladder cancer.

Seidman AD, Scher HI. Seidman AD, et al. Semin Oncol. 1991 Dec;18(6):585-95. Semin Oncol. 1991. PMID: 1775975 Review.

3

Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer.

Seidman AD, Hudis CA, Fennelly D, Raptis G, Baselga J, Norton L. Seidman AD, et al. Semin Oncol. 1995 Oct;22(5 Suppl 12):108-16. Semin Oncol. 1995. PMID: 7481852 Review.

4

Taxol and recombinant human granulocyte colony-stimulating factor, an active regimen as initial therapy for metastatic breast cancer. A preliminary report.

Reichman BS, Seidman AD, Crown JP, Heelan R, Yao TJ, Hakes TB, Lebwohl DE, Gilewski TA, Surbone A, Currie V, et al. Reichman BS, et al. Among authors: seidman ad. Ann N Y Acad Sci. 1993 Nov 30;698:398-402. doi: 10.1111/j.1749-6632.1993.tb17232.x. Ann N Y Acad Sci. 1993. PMID: 7506506 Clinical Trial. No abstract available.

5

Taxol plus recombinant human granulocyte-colony stimulating factor as initial and as salvage chemotherapy for metastatic breast cancer: a preliminary report.

Seidman AD, Reichman BS, Crown JP, Yao TJ, Heelan R, Hakes TB, Lebwohl DE, Gilewski TA, Surbone A, Currie V, et al. Seidman AD, et al. J Natl Cancer Inst Monogr. 1993;(15):171-5. J Natl Cancer Inst Monogr. 1993. PMID: 7517153

6

Flare on bone scintigraphy following Taxol chemotherapy for metastatic breast cancer.

Schneider JA, Divgi CR, Scott AM, Macapinlac HA, Seidman AD, Goldsmith SJ, Larson SM. Schneider JA, et al. Among authors: seidman ad. J Nucl Med. 1994 Nov;35(11):1748-52. J Nucl Med. 1994. PMID: 7525900 Free article. Clinical Trial.

7

Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancer.

Seidman AD, Norton L, Reichman BS, Crown JP, Yao TJ, Hakes TB, Lebwohl DE, Gilewski TA, Hudis CA, Surbone A, et al. Seidman AD, et al. Oncology. 1994 Oct;51 Suppl 1:33-9. doi: 10.1159/000227414. Oncology. 1994. PMID: 7526308 Clinical Trial.

8

Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response.

Seidman AD, Reichman BS, Crown JP, Yao TJ, Currie V, Hakes TB, Hudis CA, Gilewski TA, Baselga J, Forsythe P, et al. Seidman AD, et al. J Clin Oncol. 1995 May;13(5):1152-9. doi: 10.1200/JCO.1995.13.5.1152. J Clin Oncol. 1995. PMID: 7537798 Clinical Trial.

9

Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer: from advanced disease to adjuvant therapy.

Seidman AD, Hudis CA, Norton L. Seidman AD, et al. Semin Oncol. 1995 Aug;22(4 Suppl 8):3-8. Semin Oncol. 1995. PMID: 7543701 Clinical Trial.

10

Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor.

Seidman AD, Portenoy R, Yao TJ, Lepore J, Mont EK, Kortmansky J, Onetto N, Ren L, Grechko J, Beltangady M, et al. Seidman AD, et al. J Natl Cancer Inst. 1995 Sep 6;87(17):1316-22. doi: 10.1093/jnci/87.17.1316. J Natl Cancer Inst. 1995. PMID: 7544834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters